These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 8375431

  • 1. Are free radicals involved in the pathogenesis of idiopathic Parkinson's disease?
    Poirier J, Thiffault C.
    Eur Neurol; 1993; 33 Suppl 1():38-43. PubMed ID: 8375431
    [Abstract] [Full Text] [Related]

  • 2. Pathogenesis and animal studies of Parkinson's disease.
    Oertel WH, Kupsch A.
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
    [Abstract] [Full Text] [Related]

  • 3. The possible role of iron in the etiopathology of Parkinson's disease.
    Youdim MB, Ben-Shachar D, Riederer P.
    Mov Disord; 1993 Jun; 8(1):1-12. PubMed ID: 8419792
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis of Parkinson's disease.
    Riederer P, Lange KW.
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):295-300. PubMed ID: 1623255
    [Abstract] [Full Text] [Related]

  • 5. Type B monoamine oxidase and neurotoxins.
    Naoi M, Maruyama W.
    Eur Neurol; 1993 Jun; 33 Suppl 1():31-7. PubMed ID: 8375430
    [Abstract] [Full Text] [Related]

  • 6. [Search for the cause of Parkinson's disease].
    Langston JW.
    Arch Neurobiol (Madr); 1991 Jun; 54(6):264-71. PubMed ID: 1811457
    [No Abstract] [Full Text] [Related]

  • 7. Monoamine oxidase-B, monoamine oxidase-B inhibitors, and Parkinson's disease. A role for superoxide dismutase?
    Sandler M, Glover V, Clow A, Jarman J.
    Adv Neurol; 1993 Jun; 60():238-41. PubMed ID: 8420141
    [No Abstract] [Full Text] [Related]

  • 8. Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice.
    Mash DC, Sanchez-Ramos J, Weiner WJ.
    Adv Neurol; 1993 Jun; 60():133-9. PubMed ID: 8420130
    [No Abstract] [Full Text] [Related]

  • 9. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism.
    Chiueh CC, Miyake H, Peng MT.
    Adv Neurol; 1993 Jun; 60():251-8. PubMed ID: 8380519
    [No Abstract] [Full Text] [Related]

  • 10. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 11. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease.
    Jenner P.
    Acta Neurol Scand Suppl; 1993 Jun 19; 146():6-13. PubMed ID: 8333254
    [Abstract] [Full Text] [Related]

  • 12. Nigral degeneration in Parkinson's disease.
    Rinne JO.
    Mov Disord; 1993 Jun 19; 8 Suppl 1():S31-5. PubMed ID: 8302305
    [Abstract] [Full Text] [Related]

  • 13. The nigrostriatal system in Parkinson's disease.
    Graybiel AM, Hirsch EC, Agid Y.
    Adv Neurol; 1990 Jun 19; 53():17-29. PubMed ID: 1978514
    [Abstract] [Full Text] [Related]

  • 14. Does oxidative stress participate in nerve cell death in Parkinson's disease?
    Hirsch EC.
    Eur Neurol; 1993 Jun 19; 33 Suppl 1():52-9. PubMed ID: 8375433
    [Abstract] [Full Text] [Related]

  • 15. Free radicals and their scavengers in Parkinson's disease.
    Yoshikawa T.
    Eur Neurol; 1993 Jun 19; 33 Suppl 1():60-8. PubMed ID: 8375435
    [Abstract] [Full Text] [Related]

  • 16. [Myeloperoxidase in the neurodegenerative process of Parkinson's disease].
    Teismann P.
    Dtsch Med Wochenschr; 2014 Jan 19; 139(3):99-102. PubMed ID: 24277448
    [Abstract] [Full Text] [Related]

  • 17. [Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].
    Lange KW.
    Fortschr Neurol Psychiatr; 1989 Apr 19; 57(4):142-8. PubMed ID: 2656447
    [Abstract] [Full Text] [Related]

  • 18. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
    Di Monte DA, McCormack A, Petzinger G, Janson AM, Quik M, Langston WJ.
    Mov Disord; 2000 May 19; 15(3):459-66. PubMed ID: 10830409
    [Abstract] [Full Text] [Related]

  • 19. Nigral and adrenal grafts in parkinsonism: recent basic and clinical studies.
    Olson L, Backlund EO, Gerhardt G, Hoffer B, Lindvall O, Rose G, Seiger A, Strömberg I.
    Adv Neurol; 1987 May 19; 45():85-94. PubMed ID: 3030073
    [No Abstract] [Full Text] [Related]

  • 20. Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson's disease.
    Singh A, Mewes K, Gross RE, DeLong MR, Obeso JA, Papa SM.
    Proc Natl Acad Sci U S A; 2016 Aug 23; 113(34):9629-34. PubMed ID: 27503874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.